113 related articles for article (PubMed ID: 29947373)
1. Reducing the toxicity of amphotericin B by encapsulation using methoxy poly(ethylene glycol)-b-poly(l-glutamic acid-co-l-phenylalanine).
Yang C; Xue B; Song W; Kan B; Zhang D; Yu H; Shen N; Li X; Tang Z; Chen X
Biomater Sci; 2018 Jul; 6(8):2189-2196. PubMed ID: 29947373
[TBL] [Abstract][Full Text] [Related]
2. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
3. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
Adams ML; Andes DR; Kwon GS
Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
8. Delivery strategies of amphotericin B for invasive fungal infections.
Wang X; Mohammad IS; Fan L; Zhao Z; Nurunnabi M; Sallam MA; Wu J; Chen Z; Yin L; He W
Acta Pharm Sin B; 2021 Aug; 11(8):2585-2604. PubMed ID: 34522599
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
10. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.
Van Etten EW; Stearne-Cullen LE; ten Kate M; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2000 Mar; 44(3):540-5. PubMed ID: 10681315
[TBL] [Abstract][Full Text] [Related]
13. Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity.
Casa DM; Carraro TC; de Camargo LE; Dalmolin LF; Khalil NM; Mainardes RM
J Nanosci Nanotechnol; 2015 Jan; 15(1):848-54. PubMed ID: 26328449
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and therapeutic efficacy of amphotericin B delivered through cholesterol hemisuccinate vesicles in the treatment of experimental murine aspergillosis.
Saxena S; Khan JA; Ghosh PC
J Antimicrob Chemother; 1998 Nov; 42(5):635-42. PubMed ID: 9848448
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
17. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B.
Thanki K; Prajapati R; Sangamwar AT; Jain S
Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057
[TBL] [Abstract][Full Text] [Related]
18. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
19. PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome.
Van de Ven H; Paulussen C; Feijens PB; Matheeussen A; Rombaut P; Kayaert P; Van den Mooter G; Weyenberg W; Cos P; Maes L; Ludwig A
J Control Release; 2012 Aug; 161(3):795-803. PubMed ID: 22641062
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.
Diezi TA; Takemoto JK; Davies NM; Kwon GS
J Pharm Sci; 2011 Jun; 100(6):2064-70. PubMed ID: 21491436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]